Open Beta
MetriLume

US marketsUSPH

SEC-sourced researchBeta

USPH

U S PHYSICAL THERAPY INC /NV

Company comparison ↗

Data passport

CIK
0000885978
Exchange
NYSE
Business activity
— · SIC 8000
Financial inputs
6/6
Filing date
Oct 2, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 604,802,000.0000 USD; December 2024: 671,345,000.0000 USD; December 2025: 780,990,000.0000 USD781M USD0 USD0December 2023December 2024December 2025
USPH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023604,802,000.0000Feb 27, 2026
December 2024671,345,000.0000Feb 27, 2026
December 2025780,990,000.0000Feb 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025780,990,000.000039,583,000.000075,058,000.00001,204,010,000.0000433,811,000.0000Feb 27, 2026
December 2024671,345,000.000031,424,000.000074,940,000.00001,167,467,000.0000408,421,000.0000Feb 27, 2026
December 2023604,802,000.000028,239,000.000081,978,000.0000——Feb 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$780.99MDecember 2025Feb 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$671.35MDecember 2024Feb 27, 202610-K
Net incomeNetIncomeLoss$39.58MDecember 2025Feb 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$75.06MDecember 2025Feb 27, 202610-K
Total assetsAssets$1.2BDecember 2025Feb 27, 202610-K
Total liabilitiesLiabilities$433.81MDecember 2025Feb 27, 202610-K

New filings

Explore methodology ↗